166 related articles for article (PubMed ID: 29426913)
21. Identification of Small-Molecule Inhibitors of Neutral Ceramidase (nCDase) via Target-Based High-Throughput Screening.
Otsuka Y; Airola MV; Choi YM; Coant N; Snider J; Cariello C; Saied EM; Arenz C; Bannister T; Rahaim R; Hannun YA; Shumate J; Scampavia L; Haley JD; Spicer TP
SLAS Discov; 2021 Jan; 26(1):113-121. PubMed ID: 32734807
[TBL] [Abstract][Full Text] [Related]
22. Biocompatible Hydrogels for Microarray Cell Printing and Encapsulation.
Datar A; Joshi P; Lee MY
Biosensors (Basel); 2015 Oct; 5(4):647-63. PubMed ID: 26516921
[TBL] [Abstract][Full Text] [Related]
23. Reducing False Positives through the Application of Fluorescence Lifetime Technology: A Comparative Study Using TYK2 Kinase as a Model System.
Greenhough LA; Clarke G; Phillipou AN; Mazani F; Karamshi B; Rowe S; Rowland P; Messenger C; Haslam CP; Bingham RP; Craggs PD
SLAS Discov; 2021 Jun; 26(5):663-675. PubMed ID: 33783261
[TBL] [Abstract][Full Text] [Related]
24. Toward high-throughput drug screening on a chip-based parallel affinity separation platform.
Ohlson S; Duong-Thi MD; Bergström M; Fex T; Hansson L; Pedersen L; Guazotti S; Isaksson R
J Sep Sci; 2010 Sep; 33(17-18):2575-81. PubMed ID: 20730836
[TBL] [Abstract][Full Text] [Related]
25. PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.
Dahlin JL; Nissink JW; Strasser JM; Francis S; Higgins L; Zhou H; Zhang Z; Walters MA
J Med Chem; 2015 Mar; 58(5):2091-113. PubMed ID: 25634295
[TBL] [Abstract][Full Text] [Related]
26. GPCR assay automation for leveraging lead optimization.
Cvijic ME; Chen J; Kubala S; Nolfo J; Kolodin G; Zhang L
J Lab Autom; 2012 Aug; 17(4):266-74. PubMed ID: 22505604
[TBL] [Abstract][Full Text] [Related]
27. A High-Throughput Mass Spectrometry Assay Coupled with Redox Activity Testing Reduces Artifacts and False Positives in Lysine Demethylase Screening.
Wigle TJ; Swinger KK; Campbell JE; Scholle MD; Sherrill J; Admirand EA; Boriack-Sjodin PA; Kuntz KW; Chesworth R; Moyer MP; Scott MP; Copeland RA
J Biomol Screen; 2015 Jul; 20(6):810-20. PubMed ID: 25755264
[TBL] [Abstract][Full Text] [Related]
28. A refined cytochrome P540 IC₅₀ shift assay for reliably identifying CYP3A time-dependent inhibitors.
Li P; Lu C; Balani SK; Gan LS
Drug Metab Dispos; 2011 Jun; 39(6):1054-7. PubMed ID: 21393461
[TBL] [Abstract][Full Text] [Related]
29. A high-throughput screen for antibiotic drug discovery.
Scanlon TC; Dostal SM; Griswold KE
Biotechnol Bioeng; 2014 Feb; 111(2):232-43. PubMed ID: 23955804
[TBL] [Abstract][Full Text] [Related]
30. Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates.
Liu Y; Beresini MH; Johnson A; Mintzer R; Shah K; Clark K; Schmidt S; Lewis C; Liimatta M; Elliott LO; Gustafson A; Heise CE
J Biomol Screen; 2012 Feb; 17(2):225-36. PubMed ID: 21940710
[TBL] [Abstract][Full Text] [Related]
31. Matrix-Based Activity Pattern Classification as a Novel Method for the Characterization of Enzyme Inhibitors Derived from High-Throughput Screening.
Auld DS; Jimenez M; Yue K; Busby S; Chen YC; Bowes S; Wendel G; Smith T; Zhang JH
J Biomol Screen; 2016 Dec; 21(10):1075-1089. PubMed ID: 27601436
[TBL] [Abstract][Full Text] [Related]
32. Screening strategies to identify HSP70 modulators to treat Alzheimer's disease.
Repalli J; Meruelo D
Drug Des Devel Ther; 2015; 9():321-31. PubMed ID: 25609918
[TBL] [Abstract][Full Text] [Related]
33. Microfluidic Programming of Compositional Hydrogel Landscapes.
Allazetta S; Negro A; Lutolf MP
Macromol Rapid Commun; 2017 Aug; 38(15):. PubMed ID: 28605081
[TBL] [Abstract][Full Text] [Related]
34. [High-throughput screening of human soluble epoxide hydrolase inhibitors].
Wang SB; Guo J; Yu XM; Du GH
Yao Xue Xue Bao; 2010 Nov; 45(11):1367-72. PubMed ID: 21361036
[TBL] [Abstract][Full Text] [Related]
35. A high-throughput screen to identify novel calcineurin inhibitors.
Margassery LM; Kennedy J; O'Gara F; Dobson AD; Morrissey JP
J Microbiol Methods; 2012 Jan; 88(1):63-6. PubMed ID: 22056231
[TBL] [Abstract][Full Text] [Related]
36. A sol-gel-derived acetylcholinesterase microarray for nanovolume small-molecule screening.
Monton MR; Lebert JM; Little JR; Nair JJ; McNulty J; Brennan JD
Anal Chem; 2010 Nov; 82(22):9365-73. PubMed ID: 20949898
[TBL] [Abstract][Full Text] [Related]
37. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
[TBL] [Abstract][Full Text] [Related]
38. Comparative Molecular Dynamics Simulation of Aggregating and Non-Aggregating Inhibitor Solutions: Understanding the Molecular Basis of Promiscuity.
Ghattas MA; Bryce RA; Al Rawashdah S; Atatreh N; Zalloum WA
ChemMedChem; 2018 Mar; 13(6):500-506. PubMed ID: 29058775
[TBL] [Abstract][Full Text] [Related]
39. The Effect of Promiscuous Aggregation on in Vitro Drug Metabolism Assays.
Tres F; Posada MM; Hall SD; Mohutsky MA; Taylor LS
Pharm Res; 2019 Oct; 36(12):170. PubMed ID: 31654151
[TBL] [Abstract][Full Text] [Related]
40. The Ecstasy and Agony of Assay Interference Compounds.
Aldrich C; Bertozzi C; Georg GI; Kiessling L; Lindsley C; Liotta D; Merz KM; Schepartz A; Wang S
J Med Chem; 2017 Mar; 60(6):2165-2168. PubMed ID: 28244745
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
